Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Not yet recruiting

A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)

NCT05859217

Conditions: Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations: The University of Kansas Cancer Center - Westwood Kansas City, Kansas, United States

The University of Kansas Cancer Center - Indian Creek Overland Park, Kansas, United States

The University of Kansas Cancer Center - North Kansas City, Missouri, United States

The University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States

View Trial Details

Not yet recruiting

JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations

NCT06380348

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC

NCT06375109

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small-cell Lung Cancer, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Exercise in Patients With Advanced Non-small Cell Lung Cancer

NCT06374160

Conditions: Advanced Lung Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations: West German Cancer Center (Department of Palliative medicine and Department of Medical Oncology), University Hospital Essen Essen, North Rhine-Westphalia, Germany

View Trial Details

Not yet recruiting

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

NCT06336954

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

NCT06332950

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations: Shanghai Chest Hospital Shanghai, China

View Trial Details

Not yet recruiting

High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases

NCT06319950

Conditions: Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

NCT06306560

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

NCT06299371

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Myeloprotection With Trilaciclib in Pan-cancer Population

NCT06297811

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +34 more
Locations: Medical Oncology,Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions